CANbridge Pharmaceuticals has raised $224M in total funding.
CANbridge Pharmaceuticals has raised $224M in total disclosed funding. That places its disclosed total in the $100M–$250M range.
CANbridge Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026